[1]
“The Role of quantitative imaging biomarkers in an early FDG-PET/CT for detection of immune-related adverse events in melanoma patients: a prospective study”, Radiol Oncol, vol. 58, no. 3, pp. 335–347, Sep. 2024, Accessed: Sep. 22, 2026. Available: https://www.radioloncol.com/index.php/ro/article/view/4413